Necrotic tissue autolysis facilitation

"Necrotic tissue autolysis facilitation" refers to the enhancement or support of the endogenous process whereby necrotic (dead) tissue is broken down (self-digested) by the cell's own lysosomal enzymes after loss of viability. This process, termed *autolysis*, is a critical component of necrosis and involves the enzymatic degradation of cellular components, primarily by hydrolases released from lysosomes when membrane integrity is lost. In pathological and wound healing contexts, facilitation of necrotic tissue autolysis is important for clearing dead tissue, but is not mediated by a specific molecular receptor or defined gene/protein "target"[1][3][4][7]. The underlying biological agents are widespread cellular enzymes rather than a unique molecule that could be targeted selectively. Therapeutic relevance arises in wound management, where exogenous enzymes may be used to aid debridement and clearance of necrotic debris, yet these do not correspond to a druggable receptor or protein[4]. Autolysis is executed by lysosomal hydrolases after necrosis[4][3][1]. Not a protein, receptor, transporter, or canonical drug target[1][3][4]. No accepted abbreviation, gene, or unique protein ID applies. The process is fundamental to tissue turnover, necrosis, wound cleaning, and is widely relevant in pathology but not as a molecular target. If structured information is needed for a *molecule* that mediates this process (such as a specific hydrolase enzyme), an appropriate canonical entry should be the name of that enzyme (e.g., "Lysosomal acid hydrolase") rather than the descriptive process term.

Other names

Autolysis of necrotic tissueNecrotic tissue self-digestionCellular autolysis in necrosis

Enzymatic digestion of necrotic tissue via exogenous or endogenous hydrolases; Facilitation of lysosomal enzyme release and tissue breakdown